Roy M. Fleischmann, MD

Fleischmann discussed new modalities emerging in the rheumatology field, with the closest frontier in lupus.

Flesichmann shared highlights from his talk at RWCS 2026.

Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, address the importance of clinician confidence in biosimilars.